Onyda_XR - Drug Details
๐Ÿ“Š Estimates Onyda_XR Dialyzability By Different_Modalities

Onyda_XR

Complete Drug Information

Drug Name
Onyda_XR
Trade Names
Catapres, Kapvay
Pregnancy Category
AU: B3
Bioavailability
70โ€“80% (oral), 60โ€“70% (transdermal)
Routes of Administration
Oral, epidural, intravenous, transdermal, topical
Protein Binding
20โ€“40%%
Metabolism
Liver to inactive metabolites, 2/3 CYP2D6
Elimination
IR: 12โ€“16 hours; 41 hours in kidney failure, 48 hours for repeated dosing
Excretion
Urine (72%)
Formula
C9H9Cl2N3
Molar Mass
230.09
Onset of Action
30โ€“60 min
Duration of Action
โ‰ค 8 hours
Drug Class
โ€ข ฮฑ2-Adrenergic receptor agonist โ€ข Imidazoline receptor agonists โ€ข Anxiolytic โ€ข Sedative
Volume of Distribution
C9H9Cl2N3

๐Ÿคฐ Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.